Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology|November 27, 2024
Stiffness-Dependent Lysyl Oxidase Regulation through Hypoxia-Inducing Factor 1 Drives Extracellular Matrix Modifications in PsoriasisParvaneh Balsini, Pauline Weinzettl, David Samardzic, et al.
Developmental Cell|June 27, 2025
zHORSE as an optogenetic zebrafish strain for precise spatiotemporal control over gene expression during developmentAdam Varady, Sarah Grissenberger, Kristin Fischer, et al.
Life Science Alliance|June 5, 2024
Off-targets of BRAF inhibitors disrupt endothelial signaling and vascular barrier functionSophie Bromberger, Yuliia Zadorozhna, Julia Maria Ressler, et al.
Scientific Reports|January 9, 2021
Octenidine-based hydrogel shows anti-inflammatory and protease-inhibitory capacities in wounded human skinSaskia Seiser, Lukas Janker, Nina Zila, et al.
Clinical Proteomics|March 16, 2018
Proteomics-based insights into mitogen-activated protein kinase inhibitor resistance of cerebral melanoma metastasesNina Zila, Andrea Bileck, Besnik Muqaku, et al.
Journal of Cutaneous Pathology|December 23, 2022
Myofibroblast stroma differentiation in infiltrative basal cell carcinoma is accompanied by regulatory T-cellsJulia Maria Ressler, Nina Zila, Ana Korosec, et al.
The Lancet. Rheumatology|January 24, 2024
Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trialAnna Redl, Konstantin Doberer, Luisa Unterluggauer, et al.
Targeted Oncology|February 24, 2024
DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic MelanomaJulia Maria Ressler, Erwin Tomasich, Teresa Hatziioannou, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|February 13, 2025
Extracorporeal photopheresis induces the release of anti-inflammatory fatty acids and oxylipins and suppresses pro-inflammatory sphingosine-1-phosphateGerhard Hagn, Ara Cho, Nina Zila, et al.
Nature Cancer|January 17, 2025
Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial)Julia Maria Ressler, Maud Plaschka, Rita Silmbrod, et al.
Pageof 2